PubMed

TPO/Mpl Studies in Agnogenic Myeloid Metaplasia.

Hemavathy KC, Suppiah K, Hashmi G, Novetsky AD, Wang JC.

Cell Commun Signal. 2005 Feb 3;3(1):4.PMID: 15691382 [PubMed - as supplied by publisher]Related articlesFree article

Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.

Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J.

Exp Hematol. 2006 Dec;34(12):1617-23.PMID: 17157157 [PubMed - indexed for MEDLINE]Related articles

Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia.

Wang JC, Chen C, Lou LH, Mora M.

Leukemia. 1997 Nov;11(11):1827-32.PMID: 9369414 [PubMed - indexed for MEDLINE]Related articles

Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.

Elliot MA, Yoon SY, Kao P, Li CY, Tefferi A.

Eur J Haematol. 2002 Mar;68(3):175-9.PMID: 12068799 [PubMed - indexed for MEDLINE]Related articles

Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.

Matsumura I, Horikawa Y, Kanakura Y.

Leuk Lymphoma. 1999 Jan;32(3-4):351-8. Review.PMID: 10037033 [PubMed - indexed for MEDLINE]Related articles

Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.

Wang JC, Hashmi G.

Leuk Res. 2003 Jan;27(1):13-7.PMID: 12479847 [PubMed - indexed for MEDLINE]Related articles

Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.

Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoît Y, Sariban E.

Blood. 2006 Mar 15;107(6):2525-30. Epub 2005 Nov 29.PMID: 16317100 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.

Bartunek P, Karafiat V, Bartunkova J, Pajer P, Dvorakova M, Kralova J, Zenke M, Dvorak M.

Exp Hematol. 2008 Apr;36(4):495-505. Epub 2008 Feb 4.PMID: 18243490 [PubMed - indexed for MEDLINE]Related articles

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL.

PLoS Med. 2006 Jul;3(7):e270.PMID: 16834459 [PubMed - indexed for MEDLINE]Related articlesFree article

The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.

Geddis AE, Fox NE, Kaushansky K.

Exp Hematol. 2006 Jan;34(1):82-6.PMID: 16413394 [PubMed - indexed for MEDLINE]Related articles

Current perspective in agnogenic myeloid metaplasia.

Tefferi A, Silverstein MN.

Leuk Lymphoma. 1996 Sep;22 Suppl 1:169-71. Review.PMID: 8951788 [PubMed - indexed for MEDLINE]Related articles

Role of the thrombopoietin (TPO)/Mpl system: c-Mpl-like molecule/TPO signaling enhances early hematopoiesis in Xenopus laevis.

Kakeda M, Kyuno J, Kato T, Nishikawa M, Asashima M.

Dev Growth Differ. 2002 Feb;44(1):63-75.PMID: 11869293 [PubMed - indexed for MEDLINE]Related articles

Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.

Glembotsky AC, Korin L, Lev PR, Chazarreta CD, Marta RF, Molinas FC, Heller PG.

Eur J Haematol. 2010 Jan 22. [Epub ahead of print]PMID: 20113333 [PubMed - as supplied by publisher]Related articles

Reduced expression of TGF beta1RII in agnogenic myeloid metaplasia is not due to mutation or methylation.

Hemavathy KC, Chang TH, Zhang H, Charles W, Goldberg A, Aithal S, Novetsky AD, Wang JC.

Leuk Res. 2006 Jan;30(1):47-53. Epub 2005 Jul 28.PMID: 16054691 [PubMed - indexed for MEDLINE]Related articles

Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates.

Yoon SY, Li CY, Tefferi A.

Eur J Haematol. 2000 Sep;65(3):170-4.PMID: 11007052 [PubMed - indexed for MEDLINE]Related articles

The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Ninos JM, Jefferies LC, Cogle CR, Kerr WG.

J Transl Med. 2006 Feb 16;4:9.PMID: 16480521 [PubMed]Related articlesFree article

Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia.

van den Oudenrijn S, Bruin M, Folman CC, Bussel J, de Haas M, von dem Borne AE.

Br J Haematol. 2002 May;117(2):390-8.PMID: 11972523 [PubMed - indexed for MEDLINE]Related articles

Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.

Tiedt R, Coers J, Ziegler S, Wiestner A, Hao-Shen H, Bornmann C, Schenkel J, Karakhanova S, de Sauvage FJ, Jackson CW, Skoda RC.

Blood. 2009 Feb 19;113(8):1768-77. Epub 2008 Oct 9.PMID: 18845793 [PubMed - indexed for MEDLINE]Related articlesFree article

Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value.

Harrison CN, Gale RE, Pezella F, Mire-Sluis A, MacHin SJ, Linch DC.

Br J Haematol. 1999 Oct;107(1):139-47.PMID: 10520034 [PubMed - indexed for MEDLINE]Related articles

Thrombopoietin regulates differentiation of rhesus monkey embryonic stem cells to hematopoietic cells.

Wang Z, Skokowa J, Pramono A, Ballmaier M, Welte K.

Ann N Y Acad Sci. 2005 Jun;1044:29-40. Review.PMID: 15958695 [PubMed - indexed for MEDLINE]Related articles